186 related articles for article (PubMed ID: 14598892)
1. Use of RNA interference to inhibit integrin (alpha6beta4)-mediated invasion and migration of breast carcinoma cells.
Lipscomb EA; Dugan AS; Rabinovitz I; Mercurio AM
Clin Exp Metastasis; 2003; 20(6):569-76. PubMed ID: 14598892
[TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion.
Kim HI; Huang H; Cheepala S; Huang S; Chung J
Cancer Prev Res (Phila); 2008 Oct; 1(5):385-91. PubMed ID: 19138983
[TBL] [Abstract][Full Text] [Related]
3. Ras stimulation of E2F activity and a consequent E2F regulation of integrin alpha6beta4 promote the invasion of breast carcinoma cells.
Yoon SO; Shin S; Mercurio AM
Cancer Res; 2006 Jun; 66(12):6288-95. PubMed ID: 16778205
[TBL] [Abstract][Full Text] [Related]
4. A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells.
Chao C; Lotz MM; Clarke AC; Mercurio AM
Cancer Res; 1996 Oct; 56(20):4811-9. PubMed ID: 8841003
[TBL] [Abstract][Full Text] [Related]
5. Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin.
Chen M; Sinha M; Luxon BA; Bresnick AR; O'Connor KL
J Biol Chem; 2009 Jan; 284(3):1484-94. PubMed ID: 19011242
[TBL] [Abstract][Full Text] [Related]
6. The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo.
Lipscomb EA; Simpson KJ; Lyle SR; Ring JE; Dugan AS; Mercurio AM
Cancer Res; 2005 Dec; 65(23):10970-6. PubMed ID: 16322245
[TBL] [Abstract][Full Text] [Related]
7. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
[TBL] [Abstract][Full Text] [Related]
8. Modulation of myoepithelial-associated alpha6beta4 integrin in a breast cancer cell line alters invasive potential.
Jones JL; Royall JE; Critchley DR; Walker RA
Exp Cell Res; 1997 Sep; 235(2):325-33. PubMed ID: 9299156
[TBL] [Abstract][Full Text] [Related]
9. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures.
Rabinovitz I; Mercurio AM
J Cell Biol; 1997 Dec; 139(7):1873-84. PubMed ID: 9412479
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype.
Bonaccorsi L; Carloni V; Muratori M; Salvadori A; Giannini A; Carini M; Serio M; Forti G; Baldi E
Endocrinology; 2000 Sep; 141(9):3172-82. PubMed ID: 10965888
[TBL] [Abstract][Full Text] [Related]
11. Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer.
Diaz LK; Cristofanilli M; Zhou X; Welch KL; Smith TL; Yang Y; Sneige N; Sahin AA; Gilcrease MZ
Mod Pathol; 2005 Sep; 18(9):1165-75. PubMed ID: 15920552
[TBL] [Abstract][Full Text] [Related]
12. P-cadherin signals through the laminin receptor α6β4 integrin to induce stem cell and invasive properties in basal-like breast cancer cells.
Vieira AF; Ribeiro AS; Dionísio MR; Sousa B; Nobre AR; Albergaria A; Santiago-Gómez A; Mendes N; Gerhard R; Schmitt F; Clarke RB; Paredes J
Oncotarget; 2014 Feb; 5(3):679-92. PubMed ID: 24553076
[TBL] [Abstract][Full Text] [Related]
13. Role of α6β4 integrin in cell motility, invasion and metastasis of mammary tumors.
Soung YH; Gil HJ; Clifford JL; Chung J
Curr Protein Pept Sci; 2011 Feb; 12(1):23-9. PubMed ID: 21190525
[TBL] [Abstract][Full Text] [Related]
14. Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors.
Zahir N; Lakins JN; Russell A; Ming W; Chatterjee C; Rozenberg GI; Marinkovich MP; Weaver VM
J Cell Biol; 2003 Dec; 163(6):1397-407. PubMed ID: 14691145
[TBL] [Abstract][Full Text] [Related]
15. miR-221/222 control luminal breast cancer tumor progression by regulating different targets.
Dentelli P; Traversa M; Rosso A; Togliatto G; Olgasi C; Marchiò C; Provero P; Lembo A; Bon G; Annaratone L; Sapino A; Falcioni R; Brizzi MF
Cell Cycle; 2014; 13(11):1811-26. PubMed ID: 24736554
[TBL] [Abstract][Full Text] [Related]
16. Unique expression pattern of the alpha6beta4 integrin and laminin-5 in human prostate carcinoma.
Davis TL; Cress AE; Dalkin BL; Nagle RB
Prostate; 2001 Feb; 46(3):240-8. PubMed ID: 11170153
[TBL] [Abstract][Full Text] [Related]
17. PTH-related protein upregulates integrin alpha6beta4 expression and activates Akt in breast cancer cells.
Shen X; Falzon M
Exp Cell Res; 2006 Nov; 312(19):3822-34. PubMed ID: 16965770
[TBL] [Abstract][Full Text] [Related]
18. Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.
Shaw LM
Mol Cell Biol; 2001 Aug; 21(15):5082-93. PubMed ID: 11438664
[TBL] [Abstract][Full Text] [Related]
19. Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells.
O'Connor KL; Shaw LM; Mercurio AM
J Cell Biol; 1998 Dec; 143(6):1749-60. PubMed ID: 9852165
[TBL] [Abstract][Full Text] [Related]
20. Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling.
Kim BG; Gao MQ; Choi YP; Kang S; Park HR; Kang KS; Cho NH
Breast Cancer Res; 2012 Jun; 14(3):R88. PubMed ID: 22673183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
